Kite touts 12-month remission data from tiny CAR-T study; Ironwood exec dies in bike accident
There’s been a considerable amount of chatter in recent days over whether or not Kite $KITE can expect to win an accelerated FDA approval for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
